knowledge -WSS

knowledge

author：comprehensive 2025-09-06 04:38:17 - browse：73

Golden brain and DNA spiral illustration. -- biotech coverage from STAT — Adobe

The dream of being able to pluck a cell therapy off of a freezer shelf and speedily give it to cancer patients is materializing in the cancer world. Now, a new biotech hopes to do the same for patients with neurological conditions.

Kenai Therapeutics closed a $82 million Series A round Thursday co-led by Cure Ventures, The Column Group, and sovereign wealth fund Alaska Permanent Fund Corp. The San Diego-based biotech has big plans for that money — it’s already identified its lead drug candidate for people with Parkinson’s disease, and plans to move into a clinical trial within the next year.

Kenai — pronounced key-nigh — is developing therapies that use induced pluripotent stem cells, or iPSCs. These highly versatile organisms are derived from skin or blood cells and can be transformed into any type of cell. In Parkinson’s, the idea is that these cells would replace damaged neurons.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： FDA investigates CAR

Wikipedia

WSS

U.K. Biobank has 500,000 peoples' genome sequences available

How to pay for weight loss drugs and save Medicare

Kansas must stop changing trans people's sex listing on driver's licenses, judge says

Saudi VC loops Novo Nordisk, biotech VCs into longevity incubator

How to pay for weight loss drugs and save Medicare

Will the market for weight loss drugs really reach $100 billion?

focus

knowledge

knowledge

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Organ aging and disease risk measured by new blood test

After affirmative action ruling, medical educators look to 'holistic review'

Father who lunged at Larry Nassar comforted by deputy who pinned him down: 'I understand'

Alkermes shareholders re

North Korean leader's powerful sister says warplanes repelled US spy plane

Peter Hotez and the public health issue of online harassment

FDA approves Leqembi, a milestone in Alzheimer’s treatment

BioMarin wins approval for gene therapy to treat hemophilia A

Despite FDA concern, risk that CAR

entertainment

Pediatric cancer treatments threatened by a new FDA policy

Titanic submersible victims' family mourns: 'Enormous tragedy and devastation'

Kansas must stop changing trans people's sex listing on driver's licenses, judge says

Pediatric cancer treatments threatened by a new FDA policy

Readout Newsletter: The latest in Pfizer, Moderna, and Sanofi

Organ aging and disease risk measured by new blood test

hotspot

Wikipedia

focus

knowledge